Copyright © AcuityBio Corporation 2018. All rights reserved.

Primary Contact: jschwartz@acuitybio.com 

Created by Brodly Inc. 

Unmet Medical Need
 
  • Surgery is the most common first-line treatment for lung cancer

  • Recurrence is common and lethal 

  • No current therapy prevents recurrence

What Leading Thoracic Surgeons Say. . .

“There is great need for this drug delivery device, especially in the patient who
cannot tolerate a lobectomy who must have segmentectomy or wedge resection.This new drug delivery device is a great idea that will be embraced by surgeons…”


‐ Division of thoracic surgery, Leading metropolitan academic medical Center

“This new drug delivery device is very unique. There is no commercially
available product similar to this on the market … There should be
significant
room for using this device in lung cancer surgery.” Thoracic Surgeon regional
medical center


‐Thoracic surgeon regional medical center